Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Advanced Drug Delivery Research Group, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Biomolecules. 2020 Jul 6;10(7):1006. doi: 10.3390/biom10071006.
A peptic ulcer is an alimentary tract injury that leads to a mucosal defect reaching the submucosa. This work aimed to optimize and maximize ellagic acid (EA) loading in Ca pectinate floating beads to maximize the release for 24 h. Three factors were selected: Ca pectinate concentration (X1, 1-3 w/v %), EA concentration (X2, 1-3 w/v %) and the dropping time (X3, 10-30 min). The factorial design proposed eight formulations. The optimized EA-Ca pectinate formulation was evaluated for the gastric ulcer index and the oxidative stress parameter determination of gastric mucosa. The results indicated that the optimum EA-Ca pectinate formula significantly improved the gastric ulcer index in comparison with raw EA. The protective effect of the optimized EA-Ca pectinate formula was further indicated by the histopathological features of the stomach. The results of the study indicate that an EA formulation in the form of Ca pectinate beads would be effective for protection against gastric ulcers because of Nonsteroidal anti-inflammatory drugs (NSAID) administration.
消化性溃疡是一种导致黏膜缺损到达黏膜下层的消化道损伤。本工作旨在优化和最大限度地提高鞣花酸(EA)在海藻酸钠漂浮珠中的负载量,以实现 24 小时的最大释放。选择了三个因素:海藻酸钠浓度(X1,1-3 w/v%)、EA 浓度(X2,1-3 w/v%)和滴注时间(X3,10-30 分钟)。该实验设计提出了八种配方。对优化的 EA-海藻酸钠配方进行了胃溃疡指数和胃黏膜氧化应激参数的测定。结果表明,与原 EA 相比,优化的 EA-海藻酸钠配方能显著改善胃溃疡指数。优化的 EA-海藻酸钠配方的保护作用还通过胃的组织病理学特征得到进一步证实。研究结果表明,EA 海藻酸钠珠制剂形式将对非甾体抗炎药(NSAID)引起的胃溃疡有效。